{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:30:16Z","timestamp":1790436616972,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The in vitro erythrocyte differentiation model remains a strong, clinically relevant tool to model erythroid development in normal and disease related hematopoiesis. This model also has application to developing therapeutics for diseases related to red blood cells such as sickle cell anemia where targeting increased expression of fetal hemoglobin has been a major emphasis. Since the original protocol\u2019s publication in 2002, many groups have published modified methodologies to address issues in efficiency of maturation and terminal enucleation, as well as in scalability. While all reports have merit and show efficient enucleation, the methodologies used vary widely in technique and cytokine content. Additionally, despite the strengths in these methods, reproducibility of efficient differentiation to the point of differentiation is difficult. To address these limitations, we developed a streamlined process where total PBMCs are first primed using the original liquid culture expansion phase (published in 2002) before being differentiated with minimal input via standardized, commercially purchased semi-solid medium culture pre-supplemented with erythropoietin. Our data show this methodology to produce similar levels of CD235\/CD71 positivity as previous methods but with enhanced CD235 solo positivity and evidence of enucleated cells in comparison with other widely used methods. Given the difficulty and wide variation in in vitro differentiation techniques, we present this methodology as a streamlined methodology for production of mature erythroid cells with minimal input using easily purchased reagents.<\/jats:p>","DOI":"10.1186\/s40164-021-00244-z","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T04:03:05Z","timestamp":1635480185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Red blood cells differentiated in vitro using sequential liquid and semi-solid culture as a pre-clinical model"],"prefix":"10.1186","volume":"10","author":[{"given":"Matthew","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaneice","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Landes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payal","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Lapalombella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"issue":"43","key":"244_CR1","doi-asserted-by":"publisher","first-page":"73372","DOI":"10.18632\/oncotarget.19637","volume":"8","author":"SF Alsager","year":"2017","unstructured":"Alsager SF, et al. Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis. Oncotarget. 2017;8(43):73372\u201386.","journal-title":"Oncotarget"},{"issue":"1","key":"244_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nbt1047","volume":"23","author":"MC Giarratana","year":"2005","unstructured":"Giarratana MC, et al. Ex vivo generation of fully mature human blood cells from hematopoietic stem cells. Nat Biotechnol. 2005;23(1):69\u201374.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"244_CR3","first-page":"32","volume":"3","author":"NN Iscove","year":"1975","unstructured":"Iscove NN, Sieber F. Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture. Exp Hematol. 1975;3(1):32\u201343.","journal-title":"Exp Hematol"},{"issue":"1\u20132","key":"244_CR4","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.ddmec.2011.10.002","volume":"8","author":"AR Migliaccio","year":"2011","unstructured":"Migliaccio AR, Palio J. Blood in a dish: in vitro synthesis of red blood cells. Drug Discov Today Dis Mech. 2011;8(1\u20132):e3\u20138.","journal-title":"Drug Discov Today Dis Mech"},{"issue":"2","key":"244_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/bcmd.2002.0502","volume":"28","author":"G Migliaccio","year":"2002","unstructured":"Migliaccio G, et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28(2):169\u201380.","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"244_CR6","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/nbt1245","volume":"24","author":"K Miharada","year":"2006","unstructured":"Miharada K, Hiroyama T, Sudo K, Nagasawa T, Nakamura Y. Efficient enucleation of erythroblasts differentiated in vitro from hematopoietic stem and progenitor cells. Nat Biotechnol. 2006;24(10):1255\u20136.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"244_CR7","first-page":"742","volume":"9","author":"HA Neumann","year":"1981","unstructured":"Neumann HA, L\u00f6hr GW, Fauser AA. Radiation sensitivity of pluripotent hemopoietic progenitors (CFUGEMM) derived from human bone marrow. Exp Hematol. 1981;9(7):742\u20134.","journal-title":"Exp Hematol"},{"issue":"2","key":"244_CR8","first-page":"154","volume":"11","author":"S Ruppert","year":"1983","unstructured":"Ruppert S, L\u00f6hr GW, Fauser AA. Characterization of stimulatory activity for human pluripotent stem cells (CFUGEMM). Exp Hematol. 1983;11(2):154\u201361.","journal-title":"Exp Hematol"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-021-00244-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-021-00244-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T04:03:30Z","timestamp":1635480210000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-021-00244-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["244"],"URL":"https:\/\/doi.org\/10.1186\/s40164-021-00244-z","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Blood was obtained from healthy volunteers and patient donors following written informed consent under a protocol approved by the Institutional Review Board (IRB) of The Ohio State University (OSU; Columbus, OH) in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}